Replaces Prod. #: BML-G505
PLA2 stimulatory bee venom peptide. Sequence is similar to Phospholipase A2 Activating Peptide (Prod. No. ALX-165-007). Activates PLA2 (5-fold at 10µg/ml) in BC3H1 cells. For additional technical information see melittin (natural) (Prod. No. ALX-162-006).
Product Details
| Sequence: | H-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 |
| |
| Formula: | C131H229N39O31 |
| |
| MW: | 2846.5 |
| |
| Source: | Synthetic. |
| |
| CAS: | 37231-28-0 |
| |
| MI: | 14: 5824 |
| |
| Peptide Content: | 70-90% |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | Soluble in water. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB: M.H. Park, et al.; Prostate
71, 801 (2011),
Abstract;
Related Products
